Product news

Share this article:
Gilead Sciences has received FDA approval for the marketing of Viread (tenofovir disoproxil fumarate), for the treatment of chronic hepatitis B in adults. Viread has been available in the US for the treatment of HIV infection in adults since 2001.
Share this article:
You must be a registered member of MMM to post a comment.

This compelling e-book shares a wealth of insights designed to help members of sales forces connect with elusive HCPs. An expanded version has also been created that includes video interviews and other multimedia content. Click here for access.